Hilleman Laboratories & AstraZeneca
1 shared events · Importance 3 · Last updated Aug 06, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Accidents
Hilleman Laboratories: Developing a promising rVSV-based Bundibugyo vaccine, with WHO calling it the 'most promising' candidate. Its progress could provide a key tool against the outbreak.
AstraZeneca: Its COVID-19 vaccine technology is used in the Oxford candidate, but AstraZeneca itself is not directly involved in the Ebola response.
Mar 09, 2018 · 543 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Hilleman Laboratories and AstraZeneca interact across events, view sentiment trends, and discover connected entities.
Open Dashboard